676116-21-5

Basic information

• Product Name: 8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one
• Synonyms: 8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one;8-Chloro-4,4-dimethyl-3,4-dihydro-1H-quinolin-2-one;8-Chloro-4,4-dimethyl-3,4-dihydroquinolin-2(1H)-one
• CAS NO: 676116-21-5
• Molecular Formula: C11H12ClNO
• Molecular Weight: 209.67208
• Mol File: 676116-21-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one(676116-21-5)
• EPA Substance Registry System: 8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one(676116-21-5)

Safety Data

• Hazardous Substances Data: 676116-21-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one is used as an intermediate in the synthesis of various pharmaceuticals for its versatile chemical properties.
Used in Antimalarial Applications:
8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one is used as a key component in the development of antimalarial drugs, contributing to the creation of effective treatments against malaria.
Used in Antitumor Applications:
8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one is utilized in the synthesis of antitumor agents, playing a role in the fight against cancer.
Used in Alzheimer's Disease Treatment Research:
8-Chloro-4,4-diMethyl-1,3-dihydroquinolin-2-one is studied for its potential applications in the treatment of Alzheimer's disease, indicating its possible use in developing therapies for neurodegenerative conditions.

Upstream product

• 91089-54-2 N-(2-chlorophenyl)-3-methylbut-2-enamide 
• 95-51-2 o-chloroaniline 
• 3350-78-5 3,3-Dimethylacryloyl chloride 

Relevant articles and documents

Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential

Signal transducers and activators of transcription 5A and 5B (STAT5A and STAT5B) are two closely related STAT family members that are crucial downstream effectors of tyrosine kinase oncoproteins such as FLT3-ITD in acute myeloid leukemia (AML) and BCR-ABL

HETEROCYCLIC SUBSTITUTED PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA

This invention relates to compounds of the formula 1 wherein X, Y, Z, A, R', R2, R3, R4, R9, W' and W2 are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system and other diso